Human Adenovirus Vectors for Gene Transfer into Mammalian Cells

Advances in Pharmacology

Volumn 40, Issue C, 1997, Pages 137-206

  Hitt, Mary M ^a   Addison, Christina L ^a   Graham, Frank L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL; CELL CULTURE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; REVIEW;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS;

EID: 0030623809     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60140-4     Document Type: Article

References (385)

1. Abraham N.G., da Silva J.L., Lavrovsky Y., Stoltz R.A., Kappas A., Dunn M.W., and Schwartzman M.L. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest. Ophthalmol. Visual Sci. 36 (1995) 2202-2210
2. Acsadi G., Jani A., Huard J., Blaschuk K., Massie B., Holland P., Lochmuller H., and Karpati G. Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1 (1994) 338-340
3. Acsadi G., Jani A., Massie B., Simoneau M., Holland P., Blaschuk K., and Karpati G. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3 (1994) 579-584
4. Acsadi G., Massie B., and Jani A. Adenovirus-mediated gene transfer into striated muscle. J. Mol. Med. 73 (1995) 165-180
5. Acsadi G., Lochmuller H., Jani A., Huard J., Massie B., Prescott S., Simoneau M., Petrof B.J., and Karpati G. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7 (1996) 129-140
6. Addison C.L., Braciak T., Ralston R., Muller W.J., Gauldie J., and Graham F.L. Intra-tumoral injection of an adenovirus expressing interleukin-2 induces regression and immunity in a murine breast cancer model. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8522-8526
7. Addison C.L., Gauldie J., Muller W.J., and Graham F.L. An adenoviral vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast cancer model. Int. J. Oncol. 7 (1995) 1253-1260
8. Addison C.L., Hitt M.M., Kunsken D., and Graham F.L. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol (1997) (in press)
9. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L.D., Poenaru L., Perricaudet M., Kahn A., and Peschanski M.R. Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3 (1993) 224-228
10. Alcorn J.L., Gao E., Chen Q., Smith M.E., Gerard R.D., and Mendelson C.R. Genomic elements involved in transcriptional regulation of the rabbit surfactant protein A gene. Mol. Endocrinol. 7 (1993) 1072-1085
11. Amalfitano A., Begy C.R., and Chamberlain J.S. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3352-3356
12. Amin R., Wilmott R., Schwarz Y., Trapnell B., and Stark J. Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro. Hum. Gene Ther. 6 (1995) 145-153
13. Anton M., and Graham F.L. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: A molecular switch for control of gene expression. J. Virol. 69 (1995) 4600-4606
14. Arbuthnot P.B., Bralet M.-P., LeJossic C., Dedieu J.-F., Perricaudet M., Brechot C., and Ferry N. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum. Gene Ther. 7 (1996) 1503-1514
15. Armentano D., Sookdeo C.C., Hehir K.M., Gregory R.J., George J.A.St., Prince G.A., Wadsworth S.C., and Smith A.E. Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6 (1995) 1343-1353
16. Babiss L.E., Young C.S.H., Fisher P.B., and Ginsberg H.S. Expression of adenovirus E1A and E1B gene products and the Escherichia coli XGPRT gene in KB cells. J. Virol. 46 (1983) 454-465
17. Babiss L.E., Ginsberg H.S., and Darnell Jr. J.E. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol. 5 (1985) 2552-2558
18. Babiss L.E., Friedman J.M., and Darnell Jr. J.E. Cellular promoters incorporated into the adenovirus genome: Effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoters. Mol. Cell. Biol. 6 (1986) 3798-3806
19. Bacchetti S., and Graham F.L. Inhibition of cell proliferation by an adenovirus vector expressing the human wild type p53 protein. Int. J. Oncol. 3 (1993) 781-788
20. Bajocchi G., Feldman S.H., Crystal R.G., and Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat. Genet. 3 (1993) 229-234
21. Ballard P.L., Zepeda M.L., Schwartz M., Lopez N., and Wilson J.M. Adenovirus-mediated gene transfer to human fetal lung ex vivo. Am. J. Physiol. 268 (1995) L839-L845.
22. Barr D., Tubb J., Ferguson D., Scaria A., Lieber A., Wilson C., Perkins J., and Kay M.A. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2 (1995) 151-155
23. Barr E., Carroll J., Kalynych A.M., Tripathy S.K., Kozarsky K., Wilson J.M., and Leiden J.M. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1 (1994) 51-58
24. Bass C., Cabrera G., Elgavish A., Robert B., Siegal G.P., Anderson S.C., Maneval D.C., and Curiel D.T. Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo. Cancer Gene Ther. 2 (1995) 97-104
25. Becker T.C., Noel R.J., Coats W.S., Gomez-Foix A.M., Alam T., Gerard R.D., and Newgard C.B. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43 (1994) 161-189
26. Bennett J., Wilson J., Sun D., Forbes B., and Maguire A. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Visual Sci. 35 (1994) 2535-2542
27. Berkner K.L. Expression of heterologous sequences in adenoviral vectors. Curr. Top. Microbiol. Immunol. 158 (1992) 39-66
28. Berkner K.L., and Sharp P.A. Generation of adenovirus by transfection of plasmids. Nucleic Acids Res. 11 (1983) 6003-6020
29. Bessereau J.L., Stratford-Perricaudet L.D., Piette J., Le Poupon C., and Changeux J.P. In vivo and in vitro analysis of electrical activity dependent expression of muscle acetylcholine receptor genes using adenovirus. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1304-1308
30. Bett A.J., Prevec L., and Graham F.L. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67 (1993) 5911-5921
31. Bett A.J., Haddara W., Prevec L., and Graham F.L. An efficient and flexible system for construction of adenovirus vectors with inserts or deletion in early regions 1 and 3. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8802-8806
32. Boucher R.C., Knowles M.R., Johnson L.G., Olsen J.C., Pickles R., Wilson J.M., Engelhardt J., Yang Y., and Grossman M. Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. Hum. Gene Ther. 5 (1994) 615-639
33. Bout A., Imler J.-L., Schultz H., Perricaudet M., Zurcher C., Herbrink P., Valerio D., and Pavirani A. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: Efficacy, toxicity, and safety. Gene Ther. 1 (1994) 385-394
34. Bout A., Perricaudet M., Baskin G., Imler J.L., Scholte B.J., Pavirani A., and Valerio D. Lung gene therapy: In vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. Hum. Gene Ther. 5 (1994) 3-10
35. Boviatsis E.J., Chase M., Wei M.X., Tamiya T., Hurford Jr. R.K., Kowall N.W., Tepper R.I., Breakefield X.O., and Chiocca E.A. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5 (1994) 183-191
36. Braciak T.A., Mittal S.K., Graham F.L., Richards C.D., and Gauldie J. Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes. An approach to investigate in vivo cytokine function. J. Immunol. 151 (1993) 5145-5153
37. Braciak T.A., Bacon K., Xing Z., Torry D.J., Graham F.L., Schall T.J., Richards C.D., Croitoru K., and Gauldie J. Overexpression of RANTES using a recombinant adenovirus vector induces the tissue directed recruitment of monocytes to the lung. J. Immunol. 157 (1996) 5076-5084
38. Bramson J.L., Graham F.L., and Gauldie J. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr. Opin. Biotechnol. 6 (1995) 590-595
39. Bramson J., Hitt M., Gallichan W.S., Rosenthal K.L., Gauldie J., and Graham F.L. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12. Hum. Gene Ther. 7 (1996) 333-342
40. Bramson J., Hitt M., Addison C.L., Muller W.J., Gauldie J., and Graham F.L. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin- 12. Hum. Gene Ther. 7 (1996) 1995-2002
41. Branton P.E., Bayley S.T., and Graham F.L. Transformation by human adenoviruses. Biochim. Biophys. Acta 780 (1985) 67-94
42. Bridge E., and Ketner G. Redundant control of adenovirus late gene expression by early region 4. J. Virol. 63 (1989) 631-638
43. Bridge E., and Ketner G. Interaction of adenoviral E4 and E1b products in late gene expression. Virology 174 (1990) 345-353
44. Brody S.L., Jaffe H.A., Han S.K., Wersto R.P., and Crystal R.G. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum. Gene Ther. 5 (1994) 437-447
45. Brody S.L., Metzger M., Danel C., Rosenfeld M.A., and Crystal R.G. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5 (1994) 821-836
46. Budenz D.L., Bennett J., AIonso L., and Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest. Ophthalmol. Visual Sci. 36 (1995) 2211-2215
47. Byrnes A.P., Rusby J.E., Wood M.J.A., and Charlton H.M. Adenovrus gene transfer causes inflammation in the brain. Neuroscience 66 (1995) 1015-1024
48. Caillaud C., Akli S., Vigne E., Koulakoff A., Perricaudet M., Poenaru L., Kahn A., and Berwald-Nerter Y. Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur. J. Neurosci. 5 (1993) 1287-1291
49. Caldas C., Hahn S.A., Dacosta L.T., Redston M.S., Schutte M., Seymour A.B., Weinstein C.L., Hruban R.H., Yeo C.J., and Kern S.E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet. 8 (1994) 27-32
50. Cameron R.B., Spiess P.J., and Rosenberg S.A. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin-2, and local tumor irradiation. J. Exp. Med. 171 (1990) 249-263
51. Chang M.W., Ohno T., Gordon D., Lu M.M., Nabel G.J., Nabel E.G., and Leiden J.M. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol. Med. 1 (1995) 172-181
52. Chang M.W., Barr E., Lu M.M., Barton K., and Leiden J.M. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96 (1995) 2260-2268
53. Chen S.-H., Shine H.D., Goodman J.C., Grossman R.G., and Woo S.L.C. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3054-3057
54. Chen S.J., Wilson J.M., and Muller D.W. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 89 (1994) 1922-1928
55. Cheng J.Q., Jhanwar S.C., Klein W.M., Bell D.W., Lee W., Altomare D.A., Nobori T., Olopade O.I., Buckler A.J., and Testa J.R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res. 54 (1994) 5547-5551
56. Chroboczek J., Bieber F., and Jacrot B. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186 (1992) 280-285
57. Clayman G.L., Trapnell B.C., Mittereder N., Liu T.J., Eicher S., Zhang S., and Shillitoe E.J. Transduction of normal and malignant oral epithelium by an adenovirus vector: The effect of dose and treatment time on transduction efficiency and tissue penetration. Cancer Gene Ther. 2 (1995) 105-111
58. Clemens P.R., Krause T.L., Chan S., Korb K.E., Graham F.L., and Caskey C.T. Recombinant truncated dystrophin minigenes: Construction, expression, and adenoviral delivery. Hum. Gene Ther. 6 (1995) 1477-1485
59. Colak A., Goodman J.C., Chen S.-H., Woo S.L.C., Grossman R.G., and Shine H.D. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Hum. Gene Ther. 6 (1995) 1317-1322
60. Colby W.W., and Shenk T. Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX. J. Virol. 39 (1981) 977-980
61. Collins F.S. Cystic fibrosis: Molecular biology and therapeutic implications. Science 256 (1992) 774-779
62. Connelly S., Smith T.A.G., Dhir G., Gardner J.M., Mehaffey M.G., Zaret K.S., McClelland A., and Kaleko M. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum. Gene Ther. 6 (1995) 185-193
63. Cordier L., Duffour M.-T., Sabourin J.-C., Lee M.G., Cabannes J., Ragot T., Perricaudet M., and Haddada H. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther. 2 (1995) 16-21
64. Cotten M. Adenovirus-augmented, receptor-mediated gene delivery and some solutions to the common toxicity problems. In: Doerfler W., and Boehm P. (Eds). The Molecular Repertoire of Adenoviruses III: Biology and Pathogenesis (1995), Springer, Berlin 283-295
65. Crystal R.G., and principal investigator. Clinical protocol: A phase I study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum. Gene Ther. 6 (1995) 643-666
66. Crystal R.G., and principal investigator. Clinical protocol: Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis. Hum. Gene Ther. 6 (1995) 667-703
67. Crystal R.G., McElvaney N.G., Rosenfeld M.A., Chu C.S., Mastrangeli A., Hay J.G., Brody S.L., Jaffe H.A., Eissa N.T., and Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8 (1994) 42-51
68. Csete M.E., Afra R., Mullen Y., Drazan K.E., Benhamou P.Y., and Shaked A. Adenoviral-mediated gene transfer to pancreatic islets does not alter islet function. Transplant. Proc. 26 (1994) 756-757
69. Csete M.E., Drazan K.E., Van Bree M., McIntee D.F., McBride W.H., Bett A., Graham F.L., Busuttil R.W., Berk A.J., and Shaked A. Adenovirus-raediated gene transfer in the transplant setting. I. Conditions for expression of transferred genes in cold-preserved hepatocytes. Transplantation 57 (1994) 1502-1507
70. Csete M.E., Benhamou P.Y., Drazan K.E., Wu L., McIntee D.F., Afra R., Mullen Y., Busuttil R.W., and Shaked A. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59 (1995) 263-268
71. Curiel D.T., Agarwal S., Wagner E., and Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8850-8854
72. Cutt J.R., Shenk T., and Hearing P. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J. Virol. 61 (1987) 543-552
73. Dai Y., Schwarz E.M., Gu D., Zhang W.W., Sarvetnick N., and Verma I.M. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1401-1405
74. Daniell E. Genome structure of incomplete particles of adenovirus. J. Virol. 19 (1976) 685-708
75. Davidson B.L., Allen E.D., Kozarsky K.F., Wilson J.M., and Roessler B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat. Genet. 3 (1993) 219-223
76. Davidson D., and Hassell J.A. Overproduction of polyoma virus middle T antigen in mammalian cells through the use of an adenovirus vector. J. Virol. 61 (1987) 1226-1239
77. Defer C., Belin M.-T., Caillet-Boudin M.-L., and Boulanger P. Human adenovirushost cell interactions: Comparative study with members of subgroups B and. C. J. Virol. 64 (1990) 3661-3673
78. Descamps V., Blumenfeld N., Villeval J.L., Vainchenker W., Perricaudet M., and Beuzard Y. Erythropoietin gene transfer and expression in adult normal mice: Use of an adenovirus vector. Hum. Gene Ther. 5 (1994) 979-985
79. Dietschy J.M., Turley S.D., and Spady D.K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including man. J. Lipid Res. 34 (1993) 1637-1659
80. Doronin K.K., Zakharchuk A.N., Grinenko N.F., Yurov G.K., Krougliak V.A., and Naroditsky B.S. Expression of the gene encoding secreted placental alkaline phosphatase (SEAP) by a nondefective adenovirus vector. Gene 126 (1993) 247-250
81. Dorsch-Hasler K., Keil G.M., Weber F., Jasin M., Schaffner W., and Koszinowski U.H. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 8325-8329
82. Draghia R., Caillaud C., Manicom R., Pavirani A., Kahn A., and Poenaru L. Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther. 2 (1995) 418-423
83. Drazan K.E., Shen X.D., Csete M.E., Zhang W.W., Roth J.A., Busuttil R.W., and Shaked A. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery (St. Louis) 116 (1994) 197-204
84. Drazan K.E., Wu L., Shen X.-D., Bullington D., Jurim O., Busuttil R.W., and Shaked A. Adenovirus-mediated gene transfer in the transplant setting. III. Variables affecting gene transfer in liver grafts. Transplantation 59 (1995) 670-673
85. Drazan K.E., Wu L., Olthoff K.M., Jurim O., Busuttil R.W., and Shaked A. Transduction of hepatic allogafts achieves local levels of viral IL-10 which suppress alloreactivity in vitro. J. Surg. Res. 59 (1995) 219-223
86. Drazan K.E., Csete M.E., Shen X.-D., Bullington D., Cottle G., Busuttil R.W., and Shaked A. Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J. Surg. Res. 59 (1995) 299-304
87. Drazan K.E., Shen X.-D., Wu L., Jurim O., Busuttil R.W., and Shaked A. Adenoviral-mediated gene transfer to liver xenografts results in successful expression and protein production. Transplant. Proc. 27 (1995) 331-332
88. Dupuit F., Zahm J.-M., Pierrot D., Brezillon S., Bonnet N., Imler J.-L., Pavirani A., and Puchelle E. Regenerating cells in human airway surface epithelium represent preferential targets for recombinant adenovirus. Hum. Gene Ther. 6 (1995) 1185-1193
89. Eastham J.A., Hall S.J., Sehgal I., Wang J., Timme T.L., Yang G., Connell-Crowley L., Elledge S.J., Zhang W.-W., Harper J.W., and Thompson T.C. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res. 55 (1995) 5151-5155
90. Eastham J.A., Chen S.-H., Sehgal I., Yang G., Timme T.L., Hall S.J., Woo S.L.C., and Thompson T.C. Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum. Gene Ther. 7 (1996) 515-523
91. Eissa N.T., Chu C.S., Danel C., and Crystal R.G. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a-adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis. Hum. Gene Ther. 5 (1994) 1105-1114
92. Elliott W.M., Hayashi S., and Hogg J.C. Immunodetection of adenoviral E1A proteins in human lung tissue. Am. J. Respir. Cell Mol. Biol. 12 (1995) 642-648
93. Engelhardt J.F., Yang Y., Stratford-Perricaudet L.D., Allen E.D., Kozarsky K., Perricaudet M., Yankaskas J.R., and Wilson J.M. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat. Genet. 4 (1993) 27-34
94. Engelhardt J.F., Simon R.H., Yang Y., Zepeda M., Weber-Pendleton S., Doranz B., Grossman M., and Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Biological efficacy study. Hum. Gene Ther. 4 (1993) 759-769
95. Engelhardt J.F., Ye X., Doranz B., and Wilson J.M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6196-6200
96. Engelhardt J.F., Litzky L., and Wilson J.M. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 5 (1994) 1217-1229
97. England S.B., Nicholson L.V.B., Johnson M.A., Forrest S.M., Love D.R., Zubrzyczka-Gaarn E.E., Bulman D.E., Harris J.B., and Davies K. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (London) 343 (1990) 180-182
98. Erzurum S.C., Lemarchand P., Rosenfeld M.A., Yoo J.H., and Crystal R.G. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Res. 21 (1993) 1607-1612
99. Fallaux F.J., Kranenburg O., Cramer S.J., Houweling A., van Ormondt H., Hoeben R.C., and van der Eb A.J. Characterization of 911: A new helper cell line for the tritration and propagation of early-region-1-deleted adenovrial vectors. Hum. Gene Ther. 7 (1996) 215-222
100. Fang B., Eisensmith R.C., Wang H., Kay M.A., Cross R.E., Landen C.N., Gordon G., Bellinger D.A., Read M.S., Hu P.C., Brinkhous K.M., and Woo S.L.C. Gene therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum. Gene Ther. 6 (1995) 1039-1044
101. Fearon E.R., Pardoll D., Itaya T., Golumbek P., Levitsky H.I., Simons J.W., Karasuyama H., Vogelstein B., and Frost P. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell (Cambridge, Mass.) 60 (1990) 397-403
102. Feldman L.J., Steg P.G., Zheng L.P., Chen D., Kearney M., McGarr S.E., Barry J.J., Dedieu J.F., Perricaudet M., and Isner J.M. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J. Clin. Invest. 95 (1995) 2662-2671
103. Feng M., Cabrera G., Deshane J., Scanlon K.J., and Curiel D.T. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res. 55 (1995) 2024-2028
104. Fisher K.J., Choi H., Burda J., Chen S.-J., and Wilson J.M. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217 (1996) 11-22
105. French B.A., Mazur W., Ali N.M., Geske R.S., Finnigan J.P., Rogers G.P., Roberts R., and Raizner A.E. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation 90 (1994) 2402-2413
106. French B.A., Mazur W., Geske R.S., and Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 90 (1994) 2414-2424
107. Friedman J.M., Babiss L.E., Clayton D.F., and Darnell Jr. J.E. Cellular promoters incorporated into the adenovirus genome: Cell specificity of albumin and immunoglobulin expression. Mol. Cell. Biol. 6 (1986) 3791-3797
108. Friedrich G., and Soriano P. Promoter traps in embryonic stem cells: A genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5 (1991) 1513-1523
109. Fujita A., Sakagami D., Kanegae Y., Saito I., and Kobayashi I. Gene targeting with a replication-defective adenovirus vector. J. Virol. 69 (1995) 6180-6190
110. Fujiwara T., Grimm E.A., Mukhopadhyay T., Zhang W.-W., Owen-Schaub L.B., and Roth J.A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54 (1994) 2287-2291
111. Gage F.H., Coates P.W., Palmer T.D., Kuhn H.G., Fisher L.J., Suhonen J.O., Peterson D.A., Suhr S.T., and Ray J. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11879-11883
112. Gamier A., Cote J., Nadeau I., Kamen A., and Massie B. Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells. Cytotechnology 15 (1994) 145-155
113. Gauldie J., Graham F.L., Xing Z., Braciak T., Foley R., and Sime P.J. Adenovirus vector mediated cytokines gene transfer to lung tissue. Ann. N. Y. Acad. Sci. 796 (1996) 235-244
114. Gerard R.D., and Meidell R.S. Adenovirus vectors. In: Hames B.D., and Glover D. (Eds). DNA Cloning: A Practical Approach (1995), Oxford University Press, Oxford, UK. 285-306
115. Ghosh-Choudhury G., and Graham F.L. Stable transfer of a mouse dihydrofolate reductase gene into a deficient cell line using a human adenovirus vector. Biochem. Biopbys. Res. Commun. 147 (1987) 964-973
116. Ghosh-Choudhury G., Haj-Ahmad Y., Brinkley P., Rudy J., and Graham F.L. Human adenovirus cloning vectors based on infectious bacterial plasmids. Gene 50 (1986) 161-171
117. Ghosh-Choudhury G., Haj-Ahmad Y., and Graham F.L. Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J. 6 (1987) 1733-1739
118. Gilgenkrantz H., Duboc D., Juillard V., Couton D., Pavirani A., Guillet J.G., Briand P., and Kahn A. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Hum. Gene Ther. 6 (1995) 1265-1274
119. In: Ginsberg H.S. (Ed). "The Adenoviruses." (1984), Plenum, New York
120. s integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69 (1995) 5951-5958
121. Goldman M.J., Litzky L.A., Engelhardt J.F., and Wilson J.M. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: A preclinical toxicology study. Hum. Gene Ther. 6 (1995) 839-851
122. Goldman M.J., Yang Y., and Wilson J.M. Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nat. Genet. 9 (1995) 126-131
123. Gorziglia M.I., Kadan M.J., Yei S., Lim J., Lee G.M., Luthra R., and Trapnell B.C. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Viol. 70 (1996) 4173-4178
124. Graham F.L. Covalently closed circles of human adenovirus DNA are infectious. EMBO J. 3 (1984) 2917-2922
125. Graham F.L., and Prevec L. Adenovirus-based expression vectors and recombinant vaccines. In: Ellis R.W. (Ed). Vaccines: New Approaches to Immunological Problems (1992), Butterworth-Heinemann, Boston. 363-389
126. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36 (1977) 59-72
127. Grimm E.A., Mazumder A., Zhang H.Z., and Rosenberg S.A. Lymphokine-activated killer cell phenomenon: Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155 (1982) 1823-1841
128. Grodzicker T., and Klessig D.F. Expression of unselected adenovirus genes in human cells cotransformed with the HSV-1 TK gene and adenovirus 2 DNA. Cell (Cambridge, Mass.) 21 (1980) 453-463
129. Grubb B.R., Pickles R.J., Ye H., Yankaskas J.R., Vick R.N., Engelhardt J.F., Wilson J.M., Johnson L.G., and Boucher R.C. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (London) 371 (1994) 802-806
130. Guy C.T., Cardiff R.D., and Muller W.J. Induction of mammary tumors by expression of polyoma middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12 (1992) 954-961
131. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., and Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ. Res. 73 (1993) 1202-1207
132. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., and Finkel T. Efficient and selective adenovirus-mediated gene transfer into the vascular neointima. Circulation 88 (1993) 2838-2848
133. Guzman R.J., Hirschowitz E.A., Brody S.L., Crystal R.G., Epstein S.E., and Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 10732-10736
134. Hackett Jr. J., Tutt M., Lipscomb M., Bennett M., Koo G., and Kumar V. Origin and differentiation of natural killer cells. II. Functional and morphological studies of purified NK1.1+ cells. J. Immunol. 136 (1986) 3124-3131
135. Haddada H., Ragot T., Cordier L., Duffour M.T., and Perricaudet M. Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum. Gene Ther. 4 (1993) 703-711
136. Haddada H., Lopez M., Martinache C., Ragot T., Abina M.A., and Perricaudet M. Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 195 (1993) 1174-1183
137. Haj-Ahmad Y., and Graham F.L. Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J. Virol. 57 (1986) 267-274
138. J. Hall, S.E. Mutchnik, G. Yang, S.-H. Chen, S.L.C. Woo, T. Thompson, (1996). "An Orthotopic Model for Metastatic Mouse Prostate Cancer: Characterization and Use for Gene Therapy," Annu. Meet. Abstra. American Urological Assoc, Orlando, Florida.
139. Hanke T., Graham F.L., Lulitanond V., and Johnson D.C. Herpes simplex virus IgG Fc receptors induced using recombinant adenovirus vectors expressing glycoproteins E and I. Virology 177 (1990) 437-444
140. Hanke T., Graham F.L., Rosenthal K.L., and Johnson D.C. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65 (1991) 1177-1186
141. Harper J.W., Adami G.R., Wei N., Keyomarsi K., and Elledge S.J. The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (Cambridge, Mass.) 75 (1993) 805-816
142. Hartwell L.H., and Kastan M.B. Cell cycle control and cancer. Science 266 (1994) 1821-1828
143. Hay J.G., McElvaney N.G., Herena J., and Crystal R.G. Modfication of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. 6 (1995) 1487-1496
144. Hay R.T. The origin of adenovirus DNA replication: Minimal DNA sequence requirement in vivo. EMBO J. 4 (1985) 421-426
145. Hayashi Y., DePaoli A.M., Burant C.F., and Refetoff S. Expression of a thyroid hormone responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J. Biol. Chem. 269 (1994) 23872-23875
146. Hayashi Y., Mangoura D., and Refetoff S. A mouse model of resistance to thyroid hormone produced by somatic gene transfer of a mutant thyroid hormone receptor. Mol. Endocrinol. 10 (1996) 100-106
147. Hearing P., and Shenk T. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell (Cambridge, Mass.) 33 (1983) 695-703
148. Hearing P., Samulski R.J., Wishart W.L., and Shenk T. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J. Virol. 61 (1987) 2555-2558
149. Hersh J., Crystal R.G., and Bewig B. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2 (1995) 124-131
150. Hierholzer J.C., Wigand R., Anderson L.J., Adrian T., and Gold J.W.M. Adenoviruses from patients with AIDS: A plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J. Infect. Dis. 158 (1988) 804-813
151. Hinds P.W., and Weinberg R.A. Tumor suppressor genes. Curr. Opin. Genet. Dev. 4 (1994) 135-141
152. Hirschowitz E.A., Ohwada A., Pascal W.R., Russi T.J., and Crystal R.G. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6 (1995) 1055-1063
153. Hitt M., Bett A.J., Addison C.L., Prevec L., and Graham F.L. Techniques for human adenovirus vector construction and characterization. Methods Mol. Genet. 7 (1995) 13-30
154. Hoffman E.P., Brown Jr. R.H., and Kunkel L.M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell (Cambridge, Mass.) 51 (1987) 919-928
155. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancers. Science 253 (1991) 49-53
156. Horellou P., Vigne E., Castel M.N., Barneoud P., Colin P., Perricaudet M., Delaere P., and Mallet J. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. NeuroReport 6 (1994) 49-53
157. Huang A., Jacobi G., Haj-Ahmad Y., and Bacchetti S. Expression of the HSV-2 ribonucleotide reductase subunits in adenovirus vectors or stably transformed cells: Restoration of enzymatic activity by reassociation of enzyme subunits in the absence of other HSV proteins. Virology 163 (1988) 462-470
158. s on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69 (1995) 2257-2263
159. Huard J., Lochmuller H., Acsadi G., Jani A., Massie B., and Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2 (1995) 107-115
160. Hughes S.D., Rouy D., Navaratnam N., Scott J., and Rubin E.M. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits. Hum. Gene Ther. 7 (1996) 39-49
161. Hutchinson L., Goldsmith K., Snoddy D., Ghosh H., Graham F.L., and Johnson D.C. Indentification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J. Virol. 66 (1992) 5603-5609
162. Hutchinson L., Graham F.L., Cai W., Debroy C., Person S., and Johnson D.C. Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants. Virology 196 (1993) 514-531
163. Imler J.-L., Chartier C., Dieterle A., Dreyer D., Mehtali M., and Pavirani A. An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther. 2 (1995) 263-268
164. Imler J.-L., Bout A., Dreyer D., Dieterle A., Schultz H., Valerio D., Mehtali M., and Pavirani A. Trans-complementation of E1-deleted adenovirus: A new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Hum. Gene Ther. 6 (1995) 711-721
165. Imler J.-L., Chartier C., Dreyer D., Dieterle A., Sainte-Marie M., Faure T., Pavirani A., and Mehtali M. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther. 3 (1996) 75-84
166. Imler J.-L., Dupuit F., Chartier C., Accart N., Dieterle A., Schultz H., Puchelle E., and Pavirani A. Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter. Gene Ther. 3 (1996) 49-58
167. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., and Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92 (1993) 883-893
168. Jaffe H.A., Danel C., Longenecker G., Metzger M., Setoguchi Y., Rosenfeld M.A., Gant T.W., Thorgeirsson S.S., Stratford-Perricaudet L.D., Perricaudet M., Pavirani A., Lecocq J.-P., and Crystal R.G. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1 (1992) 372-378
169. INK4 gene mediated by an adenovirus vector. Cancer Res. 55 (1995) 3250-3253
170. Johns D.C., Nuss H.B., Chiamvimonvat N., Ramza B.M., Marban E., and Lawrence J.H. Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiomyocytes) and in vivo (rat liver). J. Clin. Invest. 96 (1995) 1152-1158
171. Johnson D.C., Ghosh-Choudhury G., Smiley J.R., Fallis L., and Graham F.L. Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164 (1988) 1-14
172. Johnson L.G. Gene therapy for cystic fibrosis. Chest 107 (1995) 77S-83S.
173. Johnson L.G., Boyles S.E., Wilson J., and Boucher R.C. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J. Clin. Invest. 95 (1995) 1377-1382
174. Jones N., and Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embyro cells. Cell (Cambridge, Mass.) 17 (1979) 683-689
175. Kamb A., Gruis N.A., Weaverfeldhaus J., Lui Q.Y., Harshman K., Tavtigian S.V., Stockert E., Day R.S., Johnson B.E., and Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 (1994) 436-440
176. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., and Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23 (1995) 3816-3821
177. Kaplan J.M., George J.A.St., Pennington S.E., Keyes L.D., Johnson R.P., Wadsworth S.C., and Smith A.E. Humoral and cellular immune responses of non-human primates to long term repeated lung exposure to Ad2/CFTR-2. Gene Ther. 3 (1996) 117-127
178. Karlsson S., Humphries R.K., Gluzman Y., and Nienhuis A.W. Transfer of genes into hematopoetic cells using recombinant DNA viruses. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 158-162
179. Kass-Eisler A., Falck-Pedersen E., Alvira M., Rivera J., Buttrick P.M., Wittenberg B.A., Cipriani L., and Leinwand L.A. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11498-11502
180. Katayose D., Gudas J., Nguyen H., Srivastava S., Cowan K.H., and Seth P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res. 1 (1995) 889-897
181. Katayose D., Wersto R., Cowan K.H., and Seth P. Effects of a recombinant adenovirus expressing WAF1/Cip 1 on cell growth, cell cycle, and apoptosis. Cell Growth Differ. 6 (1995) 1207-1212
182. Katkin J.P., Gilbert B.E., Langston C., French K., and Beaudet A.L. Aerosol delivery of a beta-galactosidase adenoviral vector to the lungs of rodents. Hum. Gene Ther. 6 (1995) 985-995
183. Kay M.A., Landen C.N., Rothenberg S.R., Taylor L.A., Leland F., Wiehle S., Fang B., Bellinger D., Finegold M., Thompson A.R., Read M., Brinkhous K.M., and Woo S.L.C. In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2353-2357
184. Kay M.A., Holterman A.-X., Meuse L., Gown A., Ochs H., Linsley P., and Wilson C.B. Long term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11 (1995) 191-197
185. Ketner G., Spencer F., Tugendreich S., Connelly C., and Hieter P. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6186-6190
186. Kleinerman D.I., Zhang W.-W., Lin S.-H., Van N.T., von Eschenbach A.C., and Hsieh J.-T. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: A preclinical study. Cancer Res. 55 (1995) 2831-2836
187. Knowles M.R., Hohneker K., Zhou Z., Olsen J.C., Noah T.L., Hu P.C., Leigh M.W., Engelhardt J.F., Edwards L.J., Jones K.R., Grossman M., Wilson J.M., Johnson L.G., and Boucher R.C. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333 (1995) 823-831
188. Kochanek S., Clemens P.R., Mitani K., Chen H.H., Chan S., and Caskey T. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5731-5736
189. Kolls J., Peppel K., Silva M., and Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adeonovirus-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 215-219
190. Kolls J.K., Lei D., Nelson S., Summer W.R., Greenberg S., and Beutler B. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171 (1995) 570-575
191. Konan V., Sahota A., Graham F.L., and Taylor M.W. Transduction of the CHO aprt gene into mouse L cells using an adeno-5/APRT recombinant virus. Somatic Cell Mol. Genet. 17 (1991) 359-368
192. Konishi H., Ochiya T., Sakamoto H., Tsukamoto M., Saito I., Muto T., Sugimura T., and Terada M. Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene. J. Clin. Invest. 96 (1995) 1125-1130
193. Kopfler W.P., Willard M., Betz T., Willard J.E., Gerard R.D., and Meidell R.S. Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation 90 (1994) 1319-1327
194. Korst R.J., Bewig B., and Crystal R.G. In vitro and in vivo transfer and expression of human surfactant SP-A- and SP-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors. Hum. Gene Ther. 6 (1995) 277-287
195. Kozarsky K., Grossman M., and Wilson J.M. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somatic Cell Mol. Genet. 19 (1993) 449-458
196. Kozarsky K.F., McKinley D.R., Austin L.L., Raper S.E., Stratford-Perricaudet L.D., and Wilson J.M. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269 (1994) 13695-13702
197. Krougliak V., and Graham F.L. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum. Gene Ther. 6 (1995) 1575-1586
198. Landau C., Pirwitz M.J., Willard M.A., Gerard R.D., Meidell R.S., and Willard J.E. Adenoviral mediated gene transfer to atherosclerotic arteries after balloon angioplasty. Am. Heart J. 129 (1995) 1051-1057
199. - adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2 (1995) 256-262
200. Lee S.W., Trapnell B.C., Rade J.J., Virmani R., and Dichek D.A. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ. Res. 73 (1993) 797-807
201. Le Gal La Salle G., Robert J.J., Berrard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M., and Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259 (1993) 988-990
202. Lemarchand P., Jaffe H.A., Danel C., Cid M.C., Kleinman H.K., Stratford-Perricaudet L., Perricaudet M., Pavirani A., Lecocq J.P., and Crystal R.G. Adenovirus-mediated transfer of a recombinant human α1-antitrypsin cDNA to human endothelial cells. Proc Natl. Acad. Sci. U.S.A. 89 (1992) 6482-6486
203. Lemarchand P., Jones M., Yamada I., and Crystal R.G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ. Res. 72 (1993) 1132-1138
204. Lemarchand P., Jones M., Danel C., Yamada I., Mastrangeli A., and Crystal R.G. In vivo adenovirus-mediated gene transfer to lungs via pulmonary artery. J. Appl. Physiol. 76 (1994) 2840-2845
205. Levrero M., Barban V., Manteca S., Ballay A., Balsamo C., Avantaggiati M.L., Natoli G., Skellekens H., Tiollais P., and Perricaudet M. Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo. Gene 101 (1991) 195-202
206. Li Q., Kay M.A., Finegold M., Stratford-Perricaudet L.D., and Woo S.L.C. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4 (1993) 403-409
207. Li T., Adamian M., Roof D.J., Berson E.L., Dryja T.P., Roessler B.J., and Davidson B.L. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Visual Sci. 35 (1994) 2543-2549
208. Li Y., Jenkins C.W., Nichols M.A., and Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9 (1994) 2261-2268
209. Lieber A., and Kay M.A. Adenovirus-mediated expression of ribozymes in mice. J. Virol. 70 (1996) 3153-3158
210. Lindgren C.G., Thompson J.A., Higuchi C.M., and Fefer A. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4. J. Immunother. 14 (1993) 322-328
211. Lippe R., and Graham F.L. Adenoviruses with nonidentical terminal sequences are viable. J. Virol. 63 (1989) 5133-5141
212. Liu T.-J., Zhang W.-W., Taylor D.L., Roth J.A., Goepfert H., and Clayman G.L. Growth suppression of human head and neck cancer cells by introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54 (1994) 3662-3667
213. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., and Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell (Cambridge, Mass.) 70 (1992) 923-935
214. Lochmuller H., Jani A., Huard J., Prescott S., Simoneau M., Massie B., Karpati G., and Ascadi G. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther. 5 (1994) 1485-1491
215. Lochmuller H., Petrof B.J., Allen C., Prescott S., Massie B., and Karpati G. Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic (mdx) mice. Biochem. Biophys. Res. Commun. 213 (1995) 569-574
216. Lotze M.T., Grimm E.A., Mazumder A., Strausser J.L., and Rosenberg S.A. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res. 41 (1981) 4420-4425
217. Lowenstein P.R., Bain D., Shering A.F., Wilkinson G.W., and Castro M.G. Cell-type specific expression from viral promoters within replication-deficient adenovirus recombinants in primary neocortical cultures. Restorative Neurol. Neurosci. 8 (1995) 37-39
218. Lowenstein P.R., Wilkinson G.W.G., Castro M.G., Shering A.F., Fooks A.R., and Bain D. Non-neurotropic adenovirus: A vector for gene transfer to the brain and possible gene therapy of neurological disorders. "Genetic Manipulation of the Nervous System," (1996), Academic Press, London. 11-39
219. Lowy D.R., and Willumsen B.M. Function and regulation of ras. Annu. Rev. Biochem. 62 (1993) 851-891
220. Maeda H., Danel C., and Crystal R.G. Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder. Gastroenterology 106 (1994) 1638-1644
221. Magness S.T., and Brenner D.A. Ferrochelatase cDNA delivered by adenoviral vector corrects biochemical defect in protoporphyic cells. Hum. Gene Ther. 6 (1995) 1285-1290
222. Mansour S.L., Grodzicker T., and Tjian R. An adenovirus vector system used to express polyoma virus tumor antigens. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 1359-1363
223. Mansour S.L., Grodzicker T., and Tjian R. Downstream sequences affect transcription initiation from the adenovirus major late promoter. Mol. Cell. Biol. 6 (1986) 2684-2694
224. March K.L., Madison J.A., and Trapnell B.C. Pharmokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: Modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum. Gene Ther. 6 (1995) 41-53
225. Mason B.B., Davis R.R., Bhat B.M., Chengalvala M., Lubeck M.D., Zandle G., Kostek B., Cholodofsky S., Dheer S., Molnar-Kimber K., Mizutani S., and Hung P.P. Adenovirus vaccine vectors expressing hepatitis B surface antigen: Importance of regulatory elements in the adenovirus major late intron. Virology 177 (1990) 452-461
226. Massie B., GIuzman Y., and Hassell J.A. Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigen. Mol. Cell. Biol. 6 (1986) 2872-2883
227. Massie B., Dionne J., Lamarche N., Fleurent J., and Langelier Y. Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. BioTechttology 13 (1995) 602-608
228. Mastrangeli A., Danel C., Rosenfeld M.A., Stratford-Perricaudet L., Perricaudet M., Pavirani A., Lecocq J.P., and Crystal R.G. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91 (1993) 225-234
229. Mastrangeli A., O'Connell B., Aladib W., Fox P.C., Baum B.J., and Crystal R.G. Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am. J. Physiol. 266 (1994) G1146-G1155
230. Mazur W., Ali N.M., Grinstead W.C., Schulz D.G., Raizner A.E., and French B.A. Lipofectin-mediated versus adenovirus-mediated gene transfer in vitro and in vivo: Comparison of canine and porcine model systems. Coronary Artery Dis. 5 (1994) 779-786
231. McCoy R.D., Davidson B.L., Roessler B.J., Huffnagle G.B., Janich S.L., Laing T.J., and Simon R.H. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6 (1995) 1553-1560
232. McCray Jr. P.B., Armstrong K., Zabner J., Miller D.W., Koretzky G.A., Couture L., Robillard J.E., Smith A.E., and Welsh M.J. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J. Clin. Invest. 95 (1995) 2620-2632
233. McGrory J., Bautista D., and Graham F.L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163 (1988) 614-617
234. Mehra M.R., Stapleton D.D., Cook J.L., Zhang T., Ventura H.O., Huang C., Maldonado B., Smart F.W., Re R.N., Murgo J.P., and Barbee R.W. Adenovirus-mediated in vivo gene transfer in a rabbit model of allograft vasculopathy. J. Heart Lung Transplant 15 (1996) 51-57
235. Mestril R., Giordano F.J., Conde A.G., and Dillmann W.H. Adenovirus mediated gene transfer of a heat shock protein 70 (hsp70i) protects against simulated ischemia. J. Mol. Cell. Cardiology 28 (1996) 2351-2358
236. Michael S.I., and Curiel D.T. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther. 1 (1994) 223-232
237. Michael S.I., Hong J.S., Curiel D.T., and Engler J.A. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2 (1995) 660-668
238. Mitani K., Graham F.L., and Caskey C.T. Transduction of human bone marrow by adenoviral vector. Hum. Gene Ther. 5 (1994) 941-948
239. Mitani K., Graham F.L., Caskey C.T., and Kochanek S. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3854-3858
240. Mitani K., Wakamiya M., Hasty P., Graham F.L., Bradley A., and Caskey C.T. Gene targeting in mouse embryoic stem cells with an adenoviral vector. Somatic Cell Mol. Genet. 21 (1995) 221-231
241. Mittal S.K., McDermott M.R., Johnson D.C., Prevec L., and Graham F.L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28 (1993) 67-90
242. Mittereder N., Yei S., Bachurski C., Cuppoletti J., Whitsett J.A., Tolstoshev P., and Trapnell B.C. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5 (1994) 717-729
243. Morris B.D., Drazan K.E., Csete M.E., Werthman P.E., Van Bree M.P., Rosenthal J.T., and Shaked A. Adenoviral-mediated gene transfer to bladder in vivo. J. Urol. 152 (1994) 506-509
244. Morsy M.A., Alford E.L., Bett A., Graham F.L., and Caskey C.T. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J. Clin. Invest. 92 (1993) 1580-1586
245. Moullier P., Friedlander G., Calise D., Ronco P., Perricaudet M., and Ferry N. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int. 45 (1994) 1220-1225
246. Muhlhauser J., Pili R., Merrill M.J., Maeda H., Passaniti A., Crystal R.G., and Capogrossi M.C. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor. Hum. Gene Ther. 6 (1995) 1457-1465
247. 165 expressed by a replication-deficient, recombinant adenovirus vector induces angiogenesis in vivo. Circ. Res. 77 (1995) 1077-1086
248. Muhlhauser J., Jones M., Yamada I., Cirielli C., Lemarchand P., Gloe T.R., Bewig B., Signoretti S., Crystal R.G., and Capogrossi M.C. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3 (1996) 145-153
249. Muller D.W., Gordon D., San H., Yang Z., Pompili V.J., Nabel G.J., and Nabel E.G. Catheter-mediated pulmonary vascular gene transfer and expression. Circ. Res. 75 (1994) 1039-1049
250. Muller W.J., Sinn E., Pattengale P.K., Wallace R., and Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell (Cambridge, Mass.) 54 (1988) 105-115
251. Munz P.L., and Young C.S.H. The creation of adenovirus genomes with viable, stable, internal redundancies centered about the E2b region. Virology 158 (1987) 52-60
252. Nevins J.R. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell (Cambridge, Mass.) 26 (1981) 213-220
253. Nevins J.R. Regulation of early adenovirus gene expression. Microbiol. Rev. 51 (1987) 419-430
254. Newman K.D., Dunn P.F., Owens J.W., Schulick A.H., Virmani R., Sukhova G., Libby P., and Dichek D. Adenovirus-mediated gene transfer into normal rabbit arteries results in a prolonged vascular cell activation, inflammation, and neointima hyperplasia. J. Clin. Invest. 96 (1995) 2955-2965
255. Nogee L.M., DeMello D.E., Dehner L.P., and Colten H.R. Brief report: Deficiency of pulmonary surfactant protein-B in congenital alveolar proteinosis. N. Engl. J. Med. 328 (1993) 406-410
256. Ohno T., Gordon D., San H., Pompili V.J., Imperiale M.J., Nabel G.J., and Nabel E.G. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265 (1994) 781-784
257. O'Malley Jr. B.W., Chen S.-H., Schwartz M.R., and Woo S.L. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude model. Cancer Res. 55 (1995) 1080-1085
258. O'Neal W.K., and Beaudet A.L. Somatic gene therapy for cystic fibrosis. Hum. Mol. Genet. 3 (1994) 1497-1502 (Spec No.)
259. Peault B., Tirouvanziam R., Sombardier M.N., Chen S., Perricaudet M., and Gaillard D. Gene transfer to human fetal pulmonary tissue developed in immunodeficient SCID mice. Hum. Gene Ther. 5 (1994) 1131-1137
260. Perez-Cruet M.J., Trask T.W., Chen S.-H., Goodman J.C., Woo S.L.C., Grossman R.G., and Shine H.D. Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res. 39 (1994) 506-511
261. Petrof B.J., Acsadi G., Jani A., Massie B., Bourdon J., Matusiewicz N., Yang L., Lochmuller H., and Karpati G. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am. J. Respir. Cell Mol. Biol. 13 (1995) 508-517
262. Philipson L., Lonberg-Holm K., and Pettersson U. Virus-receptor interaction in an adenovirus system. J. Virol. 2 (1968) 1064-1075
263. Pilder S., Moore M., Logan J., and Shenk T. The adenovirus E1B-55k transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6 (1986) 470-476
264. Pilewski J.M., Engelhardt J.F., Bavaria J.E., Kaiser L.R., Wilson J.M., and Albelda S.M. Adenovirus-mediated gene transfer to human bronchial submucosal glands using xenografts. Am. J. Physiol. 268 (1995) L657-L665
265. Pilewski J.M., Sort D.J., Wilson J.M., and Albelda S.M. ICAM-1 expression on bronchial epithelium after recombinant adenovirus infection. Am. J. Respir. Cell Mol. Biol. 12 (1995) 142-148
266. Qian C., Idoate M., AIzuguren P., Vazquez J., Bilbao R., Sangro B., Gil A., and Prieto J. Gene therapy in an experimental model of hepatocellular carcinoma (HCC). J. Hepatol. 23 (1995) 68
267. Qian C., Bilbao R., Bruna O., and Prieto J. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 22 (1995) 118-123
268. Quantin B., Perricaudet L.D., Tajbakhsh S., and Mandel J.L. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2581-2584
269. Rade J.J., Schulick A.H., Virmani R., and Dichek D.A. Local adenoviral-mediated expression of recombinant hirudin reduces neointimal formation after arterial injury. Nat. Med. 2 (1996) 293-298
270. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J.-C., Perricaudet M., and Kahn A. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscles of mdx mice. Nature (London) 361 (1993) 647-650
271. Rice A.P., and Matthews M.B. Transcriptional but not translational regulation of HIV-1 by the tat gene product. Nature (London) 332 (1988) 551-553
272. Rice A.P., and Matthews M.B. Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an Ad vector, by the adenovirus E1A 13S protein. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 4200-4204
273. Rich D.P., Couture L.A., Cardoza L.M., Guiggio V.M., Armentano D., Espino P.C., Hehir K., Welsh M.J., Smith A.E., and Gregory R.J. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum. Gene Ther. 4 (1993) 461-476
274. Richards C.D., Braciak T., Xing Z., Graham F., and Gauldie J. Adenovirus vectors for cytokine gene expression. Ann. N. Y. Acad. Sci. 762 (1995) 282-292
275. Ridoux V., Robert J.J., Zhang X., Perricaudet M., Mallet J., and LeGal La Salle G. The use of adenovirus vectors for intracerebral grafting of transfected nervous cells. NeuroReport 5 (1994) 801-804
276. Roberts R.J., O'Neill K.E., and Yen C.I. DNA sequences from the adenovirus 2 genome. J. Biol. Chem. 259 (1984) 13968-13985
277. Roessler B.J., Allen E.D., Wilson J.M., Hartman J.W., and Davidson B.L. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest. 92 (1993) 1085-1092
278. Roessler B.J., Hartman J.W., Vallance D.K., Latta J.M., Janich S.L., and Davidson B.L. Inhibition of interleukin-1 induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA, using an adenoviral vector. Hum. Gene Ther. 6 (1995) 307-316
279. Rome J.J., Shayani V., Newman K.D., Farrell S., Lee S.W., Virmani R., and Dichek D.A. Adenoviral vector-mediated gene transfer into sheep arteries using a double-balloon catheter. Hum. Gene Ther. 5 (1994) 1249-1258
280. Rosenfeld M.A., Yoshimura K., Trapnell B.C., Yoneyama K., Rosenthal E.R., DaIemans W., Fukayama M., Bargon J., Stier L.E., Stratford-Perricaudet L., Perricaudet M., Guggino W.B., Pavirani A., Lecocq J.-P., and Crystal R. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell (Cambridge, Mass.) 68 (1992) 143-155
281. Rosenfeld M.A., Chu C.S., Seth P., Danel C., Banks T., Yoneyama K., Yoshimura K., and Crystal R.G. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5 (1994) 331-342
282. Ruether J.E., Maderious A., Lavery D., Logan J., Fu S.M., and Chen-Kiang S. Cell-type-specific synthesis of murine immunoglobulin μ RNA from an adenovirus vector. Mol. Cell. Biol. 6 (1986) 123-133
283. Sabate O., Horellou P., Vigne E., Colin P., Perricaudet M., Buc-Caron M.-H., and Mallet J. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat. Genet. 9 (1995) 256-260
284. Saito I., Oya Y., Yamamoto K., Yuasa T., and Shimojo H. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 54 (1985) 711-719
285. Sarnow P., Hearing P., Anderson C.W., Halbert D.N., Shenk T., and Levine A.F. Adenovirus early region 1b 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J. Virol. 49 (1984) 692-700
286. Scaria A., Curiel D.T., and Kay M.A. Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes. Gene Ther. 2 (1995) 295-298
287. Schaack J., Langer S., and Guo X. Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase. J. Virol. 69 (1995) 3920-3923
288. Schaack J., Guo X., Ho W.Y.-W., Karlok M., Chen C., and Ornelles D. Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. J. Virol. 69 (1995) 4079-4085
289. Schachtner S.K., Rome J.J., Hoyt R.F., Newman K.D., Virmani R., and Dichek D.A. In vivo adenovirus-mediated gene transfer via the pulmonary artery of rats. Circ. Res. 76 (1995) 701-709
290. Schneider M., Graham F.L., and Prevec L. Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. J. Gen. Virol. 70 (1989) 417-427
291. Schulick A.H., Dong G., Newman K.D., Virmani R., and Dichek D.A.;. Endothelium-specific in vivo gene transfer. Circ. Res. 77 (1995) 475-485
292. Schulick A.H., Newman K.D., Virmani R., and Dichek D.A. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 91 (1995) 2407-2414
293. Sene C., Bout A., Imler J.-L., Schultz H., Willemot J.-M., Hennebel V., Zurcher C., Valerio D., Lamy D., and Pavirani A. Aerosol-mediated delivery of recombinant adeonovirus to the airways of nonhuman primates. Hum. Gene Ther. 6 (1995) 1587-1593
294. INK4. Science 267 (1995) 249-252
295. Seth P., Fitzgerald D., Ginsberg H., Willingham M., and Pastan I. Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor. Mol. Cell. Biol. 4 (1984) 1528-1533
296. Seth P., Rosenfeld M., Higginbotham J., and Crystal R.G. Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient adenovirus and unmodified plasmid DNA. J. Virol. 68 (1994) 933-940
297. Setoguchi Y., Jaffe H.A., Danel C., and Crystal R.G. Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J. Invest. Dermatol. 102 (1994) 415-421
298. Setoguchi Y., Jaffe H.A., Chu C.S., and Crystal R.G. Intraperitoneal in vivo gene therapy to deliver α1-antitrypsin to the systemic circulation. Am. J. Respir. Cell Mol. Biol. 10 (1994) 369-377
299. Setoguchi Y., Danel C., and Crystal R.G. Stimulation of erythropoiesis by in vivo gene therapy: Physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector. Blood 84 (1994) 2946-2953
300. Shaked A., Csete M.E., Drazan K.E., Bullington D., Wu L., Busuttil R.W., and Berk A.J. Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts. Transplantation 57 (1994) 1508-1511
301. M. Shaker, S.J. Hall, S.E. Mutchnik, T.L. Timme, S.-H. Chen, S.L.C. Woo, T.C. Thompson, (1996). "Combination Therapy for Prostate Cancer: Androgen Ablation and Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transduction and Ganciclovir Treatment, Ann. Meet. Abstr. American Urological Assoc, Orlando, Florida.
302. Sharp P.A., Moore C., and Haverty J.L. The infectivity of adenovirus 5 DNA-protein complex. Virology 75 (1976) 442-456
303. Shering A.F., Bain D., Stewart K., Epstein A.L., Castro M.G., Wilkinson G.W.G., and Lowenstein P.R. Cell-type specific expression in brain cell cultures from a short cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. J. Gen. Virol. 78 (1997) 445-459
304. Shy M.E., Tani M., Shi Y.-J., Whyatt S.A., Chbihi T., Scherer S.S., and Kamholz J. An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve. Ann. Neurol. 38 (1995) 429-436
305. Siegfried W., Rosenfeld M., Stier L., Stratford-Perricaudet L., Perricaudet M., Pavirani A., Lecocq J.P., and Crystal R.G. Polarity of secretion of α1-antitrypsin by human respiratory epithelial cells after adenoviral transfer of a human α1-antitrypsin cDNA. Am. J. Respir. Cell Mol. Biol. 12 (1995) 379-384
306. Simon R.H., Engelhardt J.F., Yang Y., Zepeda M., Weber-Pendleton S., Grossman M., and Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4 (1993) 771-780
307. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
308. Smith C.L., Hager G.L., Pike J.W., and Marx S.J. Overexpression of the human vitamin D3 receptor in mammalian cells using recombinant adenovirus vectors. Mol. Endocrinol. 5 (1991) 867-878
309. Smith G.M., Hale J., Pasnikowski E.M., Lindsay R., Wong V., and Rudge J.S. Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF or NT3 show enhanced support of neuronal population in vitro. Exp. Neurol. 139 (1996) 156-166
310. Smith T.A.G., Mehaffey M.G., Kayda D.B., Saunders J.M., Yei S., Trapnell B.C., McClelland A., and Kaleko M. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5 (1993) 397-402
311. Smith T.A.G., White B.D., Gardner J.M., Kaleko M., and McClelland A. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther. 3 (1996) 496-502
312. Smythe W.R., Kaiser L.R., Hwang H.C., Amin K.M., Pilewski J.M., Eck S.J., Wilson J.M., and Albelda S.M. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann. Thoracic Surg. 57 (1994) 1395-1401
313. Smythe W.R., Hwang H.C., Elshami A.A., Amin K.M., Eck S.L., Davidson B.L., Wilson J.M., Kaiser L.R., and Albelda S.M. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann. Surg. 222 (1995) 78-86
314. Spady D.K., Cuthbert J.A., Willard M.N., and Meidell R.S. Adenovirus-mediated transfer of a gene encoding cholesterol 7α-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J. Clin. Invest. 96 (1995) 700-709
315. Spector D.J., and Samaniego L.A. Construction and isolation of recombinant adenoviruses with gene replacements. Methods Mol. Genet. 7 (1995) 31-44
316. Spergel J.M., Hsu W., Akira S., Thimmappaya B., Kishimoto T., and Chen-Kiang S. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J. Virol. 66 (1992) 1021-1030
317. Steg P.G., Feldman L.J., Scoazec J.Y., Tahlil O., Barry J.J., Boulechfar S., Ragot T., Isner J.M., and Perricaudet M. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation 90 (1994) 1648-1656
318. Stevenson S.C., Rollence M., White B., Weaver L., and McClelland A. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J. Virol. 69 (1995) 2850-2857
319. Stewart P.L., Burnett R.M., Cyrklaff M., and Fuller S.D. Image reconstruction reveals the complex molecular organization of adenovirus. Cell (Cambridge, Mass.) 67 (1991) 145-154
320. Stewart P.L., Fuller S.D., and Burnett R.M. Difference imaging of adenovirus: Bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J. 12 (1993) 2589-2599
321. George J.A.St., Pennington S.E., Kaplan J.M., Peterson P.A., Kleine L.J., Smith A.E., and Wadsworth S.C. Biological response of nonhuman primates to long-term repeated lung exposure to Ad2JCFTR-2. Gene Ther. 3 (1996) 103-116
322. Stratford-Perricaudet L.D., Levrero M., Chasse J.-F., Perricaudet M., and Briand P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1 (1990) 241-256
323. Stratford-Perricaudet L.D., Makeh I., Perricaudet M., and Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90 (1992) 626-630
324. Sullivan D.M., Chung D.C., Anglade E., Nussenblatt R.B., and Csaky K.G. Adenovirus mediated gene transfer of ornithine S-aminotransferase in cultured retinal pigment epithelial cells. Invest. Ophthalmol. Visual Sci. 37 (1996) 766-774
325. Tang D.C., Johnston S.A., and Carbone D.P. Butyrate-inducible and tumor-restricted gene expression by adenoviral vectors. Cancer Gene Ther. 1 (1994) 15-20
326. Teng B., Blumenthal S., Forte T., Navaratnam N., Scott J., Gotto A.M., and Chan L. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J. Biol. Chem. 269 (1994) 29395-29404
327. Teramoto S., Johnson L.G., Huang W., Leigh M.W., and Boucher R.C. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum. Gene Ther. 6 (1995) 1045-1053
328. Thimmappaya B., Weinberger C., Scheider R.J., and Shenk T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (Cambridge, Mass.) 31 (1982) 543-551
329. Thummel C., Tjian R., and Grodzicker T. Construction of adenovirus expression vectors by site-directed in vivo recombination. J. Mol. Appl. Genet. 1 (1982) 435-446
330. Thummel C., Tjian R., Hu S.-L., and Grodzicker T. Translational control of SV40 T antigen expressed from the adenovirus late promoter. Cell (Cambridge, Mass.) 33 (1983) 455-464
331. Tracey K.J., and Cerami A. Tumor necrosis factor: An updated review of its biology. Crit. Care Med. 21 (1993) S415-S422
332. Trapnell B.C. Adenoviral vectors for gene transfer. Adv. Drug Delivery Rev. 12 (1993) 185-199
333. Tripathy S.K., Goldwasser E., Lu M.-M., Barr E., and Leiden J.M. Stable delivery of physiologic levels of recombinant erythropoeitin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11557-11561
334. Tripathy S.K., Black H.B., Goldwasser E., and Leiden J.M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2 (1996) 545-550
335. Ueno T., Miyamura T., Saito I., and Mizuno K. Immortalization of differentiated human hepatocytes by a combination of a viral vector and collagen gel culture. Hum. Cell 6 (1993) 126-136
336. Van Doren K., and Gluzman Y. Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants. Mol. Cell. Biol. 4 (1984) 1653-1656
337. Van Doren K., Hanahan D., and Gluzman Y. Infection of eucaryotic cells by helper-independent recombinant adenoviruses: Early region 1 is not obligatory for integration of viral DNA. J. Virol. 50 (1984) 606-614
338. Varley A.W., Coulthard M.G., Meidell R.S., Gerard R.D., and Munford R.S. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5346-5350
339. Verhaagen J., Hermens W.T.J.M.C., Holtmaat A.J.G.D., Oestreicher A.B., Gispen W.H., and Kaplitt M.G. Viral vector-mediated gene transfer in the nervous system: Application to the reconstruction of neural circuits in the injured mammalian brain. "Viral Vectors," (1995), Academic Press, San Diego, CA. 119-132
340. Vilquin J.-T., Guerette B., Kinoshita I., Roy B., Goulet M., Gravel C., Roy R., and Tremblay J.P. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6 (1995) 1391-1401
341. Vincent A.J.P.E., Vogels R., Someren G., Esandi M.C., Noteboom J.L., Avezaat C.J.J., Vecht C., Bekkum D.W., Valerio D., Bout A., and Hoogerbrugge P.M. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum. Gene Ther. 7 (1996) 197-206
342. Vincent M.C., Trapnell B.C., Baughman R.P., Wert S.E., Whitsett J.A., and Iwamoto H.S. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum. Gene Ther. 6 (1995) 1019-1028
343. Vincent N., Ragot T., Gilgenkrantz H., Couton D., Chafey P., Grégoire A., Briand P., Kaplan J.-C., Kahn A., and Perricaudet M. Long term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat. Genet. 5 (1993) 130-134
344. Wang P., Anton M., Graham F.L., and Bacchetti S. High frequency recombination between loxP sites in human chromosomes mediated by an adenovirus vector expressing Cre recombinase. Somatic Cell Mol. Genet. 21 (1995) 429-441
345. Wang Q., and Taylor M.W. Correction of a deletion mutant by gene targeting with an adenovirus vector. Mol. Cell. Biol. 13 (1993) 918-927
346. Welsh M.J., Zabner J., Graham S.M., Smith A.E., Moscicki R., and Wadsworth S. Adenovirus-mediated gene transfer for cystic fibrosis: Part A. Safety of dose and repeat administration in the nasal epithelium. Part B. Clinical efficacy in the maxillary sinus. Hum. Gene Ther. 6 (1995) 205-218
347. White E., Cipriani R., Sabbatini P., and Denton A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65 (1991) 2968-2978
348. s promote adenovirus internalization but not virus attachment. Cell (Cmabridge, Mass.) 73 (1993) 309-319
349. Wilson G.M., and Graham F.L. The effect of E1 mutations on biochemical transformation by an adenovirus carrying the herpes simplex virus thymidine kinase gene in region E3. Virus Res. 13 (1989) 29-44
350. Wilson J.M., and principal investigator. Clinical protocol: Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: A phase I trial. Hum. Gene Ther. 5 (1994) 501-519
351. Witmer L.A., Rosenthal K.L., Graham F.L., Friedman H.M., Yee A., and Johnson D.C. Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins. J. Gen. Virol. 71 (1990) 387-396
352. Wold W.S., and Gooding L.R. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol. Biol. Med. 6 (1989) 433-452
353. Wrighton C.J., Hofer-Warbinek R., Moll T., Eytner R., Bach F.H., and de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IkBα, an inhibitor of the transcription factor NF-kB. J. Exp. Med. 183 (1996) 1013-1022
354. Xing Z., Braciak T., Jordana M., Croitoru K., Graham F.L., and Gauldie J. Adenovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J. Immunol. 153 (1994) 4059-4069
355. Xing Z., Braciak T., Ohkawara Y., Sallenave J.-M., Foley R., Sime P.J., Jordana M., Graham F.L., and Gauldie J. Gene transfer for cytokine functional studies in the lung: The multifunctional role of GM-CSF in pulmonary inflammation. J. Leukocyte Biol. 59 (1996) 481-488
356. Xing Z., Ohkawara Y., Jordana M., Graham F.L., and Gauldie J. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest. 97 (1996) 1102-1110
357. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., and Beach D. p21 is a universal inhibitor of cyclin kinase. Nature (London) 366 (1993) 701-704
358. Xu Z.Z., Krougliak V., Prevec L., Graham F.L., and Both G.W. Investigation of promoter function in human and animal cells infected with human recombinant adenovirus expressing rotavirus antigen. VP7sc. J. Gen. Virol. 76 (1995) 1971-1980
359. Yamada M., Lewis J.A., and Grodzicker T. Overproduction of the protein product of a non-selected foreign gene carried by an adenovirus vector. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 3567-3571
360. Yang C., Cirielli C., Capogrossi M.C., and Passaniti A. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res. 55 (1995) 4210-4213
361. Yang Y., and Wilson J.M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155 (1995) 2564-2570
362. Yang Y., Raper S.E., Cohn J.A., Engelhardt J.F., and Wilson J.M. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4601-4605
363. Yang Y., Nunes F.A., Berencsi K., Furth E.F., Gonczol E., and Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4407-4411
364. Yang Y., Ertl H.C., and Wilson J.M. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1 (1994) 433-442
365. Yang Y., Nunes F.A., Berencsi K., Gonczol E., Engelhardt J.F., and Wilson J.M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7 (1994) 362-369
366. Yang Y., Li Q., Ertl H.C.J., and Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69 (1995) 2004-2015
367. Yang Y., Trinchieri G., and Wilson J.M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1 (1995) 890-893
368. Yang Y., Jooss K.U., Su Q., Ertl H.C.J., and Wilson J.M. Immune responses to viral antigens vs. transgene product in the elimination of recombinant adenovirus infected hepatocytes in vivo. Gene Ther. 3 (1996) 137-144
369. Yang Z.-Y., Perkins N.D., Ohno T., Nabel E.G., and Nabel G.J. The p21 cyclindependent kinase inhibitor suppresses tumorigenicity in vivo. Nat. Med. 1 (1995) 1052-1056
370. Yarosh O.K., Wandeler A.I., Graham F.L., Campbell J.B., and Prevec L. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14 (1996) 1257-1264
371. Yeh P., Dedieu J.F., Orsini C., Vigne E., Denefle P., and Perricaudet M. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70 (1996) 559-565
372. Yei S., Mittereder N., Wert S., Whitsett J.A., Wilmott R.W., and Trapnell B.C. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5 (1994) 731-744
373. Yei S., Mittereder N., Tang K., O'Sullivan C., and Trapnell B.C. Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1 (1994) 192-200
374. Yei S., Bachurski C.J., Weaver T.E., Wert S.E., Trapnell B.C., and Whitsett J.A. Adenoviral-mediated gene transfer of human surfactant protein B to respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol. 11 (1994) 329-336
375. Yoo J.-H., Erzurum S.C., Hay J.G., Lemarchand P., and Crystal R.G. Vulnerability of the human airway epithelium to hyperoxia. J. Clin. Invest. 93 (1994) 297-302
376. York I.A., Roop C., Andrews D.W., Riddell S.R., Graham F.L., and Johnson D.C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 + T lymphocytes. Cell (Cambridge, Mass.) 77 (1994) 525-535
377. Yoshimura K., Rosenfeld M.A., Seth P., and Crystal R.G. Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors. J. Biol. Chem. 268 (1993) 2300-2303
378. Yu D., Matin A., Xia W., Sorgi F., Huang L., and Hung M.-C. Liposome-mediated in vivo E1 A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. Oncogene 11 (1995) 1383-1388
379. Zabner J., Couture L.A., Gregory R.J., Graham S.M., Smith A.E., and Welsh M.J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell (Cambridge, Mass.) 75 (1993) 207-216
380. Zabner J., Petersen D.M., Puga A.P., Graham S.M., Couture L.A., Keyes L.D., Lukason M.J., George J.A.St., Gregory R.J., Smith A.E., and Welsh M.J. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6 (1994) 75-83
381. Zabner J., Couture L.A., Smith A.E., and Welsh M.J. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: Efficiency of adenovirus-mediated gene transfer in vitro. Hum. Gene Ther. 5 (1994) 585-593
382. Zhang J.-F., Hu C., Geng Y., Selm J., Klein S.B., Orazi A., and Taylor M.W. Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 4513-4518
383. Zhang W.-W., Alemany R., Wang J., Koch P.E., Ordonez N.G., and Roth J.A. Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum. Gene Ther. 6 (1995) 155-164
384. Zhang Y., Yu D., Xia W., and Hung M.-C. HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model. Oncogene 10 (1995) 1947-1954
385. Zhu X., Young C.S.H., and Silverstein S. Adenovirus vector expressing functional herpes simplex virus ICPO. J. Virol. 62 (1988) 4544-4553 Zsengeller, Z. K., Wert, S. E., Hull, W.